Does Neffy Cause Nasal Irritation?
Yes, Neffy (epinephrine nasal spray) commonly causes nasal irritation after use. Clinical trials reported nasal discomfort, burning, or soreness in about 13% of patients, compared to 3% with placebo.[1][2] This stems from the spray's formulation, which delivers epinephrine through the nasal mucosa, sometimes triggering transient irritation from the propellant or pH adjusters.
How Common and Severe Is It?
Irritation is typically mild and short-lived, resolving within minutes to hours. In pivotal trials (e.g., Phase 3 studies for anaphylaxis), 12-15% of users experienced nasal symptoms like pruritus (itching), erythema (redness), or pain post-dose, versus under 5% in IM epinephrine groups.[1][3] No serious nasal adverse events occurred, and symptoms didn't impair efficacy in treating anaphylaxis.
What Do Patients Report?
User reviews and post-marketing data highlight nasal dripping, stuffiness, or a "burning sensation" as frequent complaints. On platforms like Drugs.com, about 20% of Neffy reviews mention nasal issues, often describing it as tolerable but noticeable compared to auto-injectors like EpiPen.[4] Some users prefer it despite this for its needle-free design.
How Does It Compare to EpiPen or Auvi-Q?
Neffy has higher nasal irritation rates (13%) than intramuscular epinephrine (2-5%), which bypasses the nose entirely.[2][3] EpiPen users report injection-site pain instead (up to 10%). Auvi-Q, another IM option, has similar low nasal effects (none). Neffy's nasal route avoids needles but trades that for mucosal side effects.
Tips to Minimize Irritation
Blow your nose gently before use to clear passages. Alternate nostrils if readministering a second dose (recommended 5 minutes apart). Avoid if you have nasal polyps or recent surgery—consult a doctor.[1][5] The label advises monitoring for worsening symptoms.
When to Worry About Nasal Symptoms
Seek medical help if irritation persists beyond hours, includes bleeding, swelling, or breathing difficulty, as it could signal allergy or improper use rather than typical side effects.[5]
Sources
[1]: Neffy Prescribing Information (FDA)
[2]: ARALAZE Phase 3 Trial Results (NEJM, 2024)
[3]: Neffy Safety Data (J&J Press Release)
[4]: Drugs.com User Reviews
[5]: Neffy Patient Guide (ARALAZE)